HI
VRTX icon

Handelsinvest Investeringsforvaltning’s Vertex Pharmaceuticals VRTX Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.41M Sell
3,375
-610
-15% -$258K 0.68% 34
2023
Q4 		$1.62M Buy
+3,985
New +$1.47M 0.66% 30

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's VRTX Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Vertex Pharmaceuticals (VRTX) stake by 15% in Q1 2024, selling an estimated $258K and leaving 3,375 shares worth $1.41M. The position accounts for 0.68% of the portfolio, ranked #34.

Handelsinvest Investeringsforvaltning first reported a position in VRTX in Q4 2023 and has held it in 2 quarters since. The position peaked at $1.62M in Q4 2023. 1,494 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 3,375 shares of Vertex Pharmaceuticals worth $1.41M as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 610 Vertex Pharmaceuticals shares in Q1 2024, an estimated $258K.
  • Vertex Pharmaceuticals made up 0.68% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #34 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Vertex Pharmaceuticals position peaked at $1.62M in Q4 2023.
  • 1,494 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.